A possible fix for problems in small molecule manufacture via continuous flow processing.

Experts discuss how to tackle biopharma's need to move fast.

The FDA has approved just three biosimilars in 2021 – but the approvals could shake up the field as discussions around interchangeability intensify.

Setting its sights on self-amplifying RNA, AstraZeneca has signed a deal with Imperial College London spinoff VaxEquity.

Biotech companies need good patient samples, but hospitals are not always obliging...

Researchers at Trinity College Dublin explain how they are reaching into the natural environment to source new bioactives.

Analytical science has a key role to play in the development of new pharmaceutical products – from discovery, to protein analysis, to quality control.

A University of Buffalo team has produced a reverse vaccination to help manage the symptoms of various chronic and autoimmune conditions.

Sai Rangarao has worked for some of the biggest names in pharma. Here’s his advice to digital marketers in the field.

A wall of data stands between humankind and a revolution in our understanding of the body and its systems. AI can tear it down.